Immunoproteasome deficiency in non-small cell lung cancer and its relevance to immunotherapy.
作者信息
Kast Juergen
机构信息
The Biomedical Research Centre, University of British Columbia, Vancouver, Canada; Department of Chemistry, University of British Columbia, Vancouver, Canada.
出版信息
J Thorac Dis. 2016 Sep;8(9):E1082-E1086. doi: 10.21037/jtd.2016.08.80.
Abstract
摘要
相似文献
1
Immunoproteasome deficiency in non-small cell lung cancer and its relevance to immunotherapy.
J Thorac Dis. 2016 Sep;8(9):E1082-E1086. doi: 10.21037/jtd.2016.08.80.
2
Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome.
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):E1555-64. doi: 10.1073/pnas.1521812113. Epub 2016 Feb 29.
3
Immunoproteasomes and immunotherapy-a smoking gun for lung cancer?
J Thorac Dis. 2016 Jul;8(7):E558-63. doi: 10.21037/jtd.2016.05.21.
4
Interferon-dependent immunoproteasome activity during mouse adenovirus type 1 infection.
Virology. 2016 Nov;498:57-68. doi: 10.1016/j.virol.2016.08.009. Epub 2016 Aug 22.
5
Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice.
Oncotarget. 2017 Feb 7;8(31):50873-50888. doi: 10.18632/oncotarget.15141. eCollection 2017 Aug 1.
6
Immunoproteasome subunit deficiency has no influence on the canonical pathway of NF-κB activation.
Mol Immunol. 2017 Mar;83:147-153. doi: 10.1016/j.molimm.2017.01.019. Epub 2017 Jan 31.
7
Regulation of immunoproteasome function in the lung.
Sci Rep. 2015 May 19;5:10230. doi: 10.1038/srep10230.
8
Immunoproteasome Subunits Are Required for CD8 T Cell Function and Host Resistance to Brucella abortus Infection in Mice.
Infect Immun. 2018 Feb 20;86(3). doi: 10.1128/IAI.00615-17. Print 2018 Mar.
9
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma.
Pharmacol Ther. 2018 Feb;182:176-192. doi: 10.1016/j.pharmthera.2017.09.001. Epub 2017 Sep 11.
10
Immunotherapy in non-small-cell lung carcinoma: from inflammation to vaccination.
Clin Lung Cancer. 2009 Mar;10(2):99-105. doi: 10.3816/CLC.2009.n.012.
引用本文的文献
1
The Effect of a TLR3 Agonist on Airway Allergic Inflammation and Viral Infection in Immunoproteasome-Deficient Mice.
Viruses. 2024 Aug 29;16(9):1384. doi: 10.3390/v16091384.
2
Caged aminoluciferin probe for bioluminescent immunoproteasome activity analysis.
RSC Chem Biol. 2024 Jul 16;5(9):877-883. doi: 10.1039/d4cb00148f. eCollection 2024 Aug 28.
3
Interplay between proteasome function and inflammatory responses in e-cig vapor condensate-challenged lung epithelial cells.
Arch Toxicol. 2023 Aug;97(8):2193-2208. doi: 10.1007/s00204-023-03504-5. Epub 2023 Jun 22.
4
USP22 promotes development of lung adenocarcinoma through ubiquitination and immunosuppression.
Aging (Albany NY). 2020 Apr 15;12(8):6990-7005. doi: 10.18632/aging.103056.
5
Expression of Immunoproteasome Subunit LMP7 in Breast Cancer and Its Association with Immune-Related Markers.
Cancer Res Treat. 2019 Jan;51(1):80-89. doi: 10.4143/crt.2017.500. Epub 2018 Feb 26.
6
From biological mechanisms to clinical implications: the role of mineral dust-induced gene in lung cancers.
J Thorac Dis. 2017 May;9(5):1178-1181. doi: 10.21037/jtd.2017.05.14.
本文引用的文献
1
Non-small cell lung cancer: current treatment and future advances.
Transl Lung Cancer Res. 2016 Jun;5(3):288-300. doi: 10.21037/tlcr.2016.06.07.
2
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination.
Nat Rev Clin Oncol. 2016 Aug;13(8):473-86. doi: 10.1038/nrclinonc.2016.58. Epub 2016 May 4.
3
Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome.
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):E1555-64. doi: 10.1073/pnas.1521812113. Epub 2016 Feb 29.
4
Recent considerations in the use of recombinant interferon gamma for biological therapy of atopic dermatitis.
Expert Opin Biol Ther. 2016;16(4):507-14. doi: 10.1517/14712598.2016.1135898. Epub 2016 Mar 3.
5
New Insights into the Function of the Immunoproteasome in Immune and Nonimmune Cells.
J Immunol Res. 2015;2015:541984. doi: 10.1155/2015/541984. Epub 2015 Oct 8.
6
Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry.
Mol Cell Proteomics. 2015 Dec;14(12):3105-17. doi: 10.1074/mcp.O115.052431.
7
Interferon-γ Inhibits Ebola Virus Infection.
PLoS Pathog. 2015 Nov 12;11(11):e1005263. doi: 10.1371/journal.ppat.1005263. eCollection 2015.
8
The immunoproteasome: a novel drug target for autoimmune diseases.
Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 92):S74-9. Epub 2015 Oct 12.
9
MHC class I antigen presentation and implications for developing a new generation of therapeutic vaccines.
Ther Adv Vaccines. 2014 May;2(3):77-89. doi: 10.1177/2051013614525375.
10
MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia.
Sci Transl Med. 2013 Sep 18;5(203):203ra125. doi: 10.1126/scitranslmed.3006061.
Zotero 插件